G Tarantini
Overview
Explore the profile of G Tarantini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martino E, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, et al.
ESMO Open
. 2025 Jan;
10(2):104084.
PMID: 39778329
Background: Daratumumab-refractory multiple myeloma (Dara-R MM) presents a significant treatment challenge. This study aimed to evaluate the efficacy and survival outcomes of elotuzumab, pomalidomide, and dexamethasone (EloPd) in a large,...
2.
Giordani A, Candelora A, Fiacca M, Cheng C, Barberio B, Baritussio A, et al.
Int J Cardiol
. 2023 Feb;
376:165-171.
PMID: 36738845
Background: Myocarditis and inflammatory bowel diseases (IBD) are rare conditions, but may coexist. Myocarditis in IBD may be infective, immune-mediated, or due to mesalamine toxicity. A gap of knowledge exists...
3.
Mele G, Cascavilla N, Di Renzo N, Guarini A, Mazza P, Melillo L, et al.
Ann Hematol
. 2022 May;
101(8):1727-1739.
PMID: 35587825
We report herein a multicentre retrospective analysis of 192 consecutive patients with symptomatic refractory/relapsed multiple myeloma (RRMM) treated with daratumumab in combination with bortezomib or lenalidomide as salvage therapy at...
4.
Golino L, Caiazzo G, Calabro P, Colombo A, Contarini M, Fedele F, et al.
Int J Cardiol
. 2022 Jan;
350:19-26.
PMID: 34995700
Excimer Laser Coronary Atherectomy (ELCA) is a well-established therapy that emerged for the treatment of peripheral vascular atherosclerosis in the late 1980s, at a time when catheters and materials were...
5.
Mazzeo S, Cervelli R, Elisei R, Tarantini G, Cappelli C, Molinaro E, et al.
J Endocrinol Invest
. 2018 Apr;
41(12):1389-1399.
PMID: 29687416
Purpose: Surgical removal is recommended for recurrent thyroid carcinomas (RTCs) unable to uptake radioiodine and/or not responsive to chemotherapy. However, repeated neck dissection is difficult for surgeons. Thus, radiofrequency ablation...
6.
Tona F, Osto E, Famoso G, Previato M, Fedrigo M, Vecchiati A, et al.
Am J Transplant
. 2015 Mar;
15(5):1400-6.
PMID: 25766634
Coronary microvascular dysfunction is emerging as a strong predictor of outcome in heart transplantation (HT). We assessed the validity of microvascular dysfunction, defined by means of a reduced coronary flow...
7.
Mele G, Melpignano A, Quarta G, Palumbo G, Capalbo S, Falcone A, et al.
Leuk Res
. 2015 Feb;
39(3):279-83.
PMID: 25636354
This current retrospective multicenter analysis represents, to our knowledge, the first Italian study evaluating the efficacy and toxicity profile of "lenalidomide plus dexamethasone" as salvage therapy in patients with recurrent-refractory...
8.
Facchin M, Mojoli M, Covolo E, Tarantini G
Minerva Med
. 2014 Oct;
105(6):497-500.
PMID: 25283260
Transcatheter aortic valve implantation (TAVI) has become an accepted alternative treatment option for high-risk or inoperable patients with symptomatic severe aortic stenosis. The future challenge for TAVI devices is to...
9.
DAmico G, Fabris T, Mojoli M, Napodano M, Frigo A, Buja P, et al.
Minerva Cardioangiol
. 2014 Feb;
62(1):9-18.
PMID: 24500213
Aim: Aim of the present study was to assess stent- and patient-related outcomes of the first- vs. second-generation drug-eluting stents (DES) in diabetics, according to the insulin requirement status. Methods:...
10.
Tarantini G, Fraccaro C, Napodano M, Buja P, Tarzia V, Isabella G, et al.
Minerva Cardioangiol
. 2013 Nov;
61(6):691-700.
PMID: 24253461
Despite major advances in the treatment of heart failure over the past two decades, improving the natural history of this condition, heart failure continues to be a major source of...